Human medicinal product

Formal requirements

ZL000_00_020e_WL Guidance document Formal requirements (PDF, 6 MB, 01.01.2024)

ZL000_00_006e_VZ Directory Overview of documents to be submitted (XLSX, 129 kB, 01.01.2024)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

Submissions

www.swissmedicinfo.ch

Product information for human medicinal products and packaging

ZL000_00_021e_WL Guidance document Packaging for human medicinal products (PDF, 744 kB, 01.01.2024)

ZL000_00_027e_WL Guidance document Product information for human medicinal products (PDF, 1 MB, 01.02.2024)

ZL000_00_049e_WL Guidance document Involvement of patient organisation in the review of Patient Information (PDF, 1 MB, 21.07.2023)

ZL000_00_050e_WL Guidance document Mobile technologies (PDF, 1 MB, 01.10.2023)

ZL000_00_040e_FO Mobile technologies (DOCX, 371 kB, 01.10.2023)

ZL000_00_048d_VL Fachinformation für Humanarzneimittel (DOCX, 167 kB, 01.03.2023)

ZL000_00_049d_VL Patienteninformation für Humanarzneimittel (DOCX, 165 kB, 01.03.2023)

Questions and answers on Full declaration HMV4

ZL000_00_038d_MB Merkblatt Mustertext NSAR Selbstmedikation PI HMV4 (PDF, 178 kB, 01.01.2019)

ZL000_00_039d_MB Merkblatt Mustertext NSAR Selbstmedikation FI HMV4 (PDF, 141 kB, 01.01.2019)

ZL000_00_040d_MB Merkblatt Mustertext rezeptpflichtige NSAR Fachinformation HMV4 (PDF, 234 kB, 01.01.2019)

ZL000_00_041d_MB Merkblatt Mustertext rezeptpflichtige NSAR Patienteninformation HMV4 (PDF, 215 kB, 01.01.2019)

ZL000_00_042d_MB Mustertext für Acetylsalicylsäure Selbstmedikation Fachinformation (PDF, 729 kB, 01.05.2023)

ZL000_00_043d_MB Merkblatt Mustertext für Paracetamol Selbstmedikation Fachinformation HMV4 (PDF, 606 kB, 01.06.2021)

www.swissmedicinfo.ch

Time limits for authorisation applications

ZL000_00_014e_WL Guidance document Time limits for authorization applications (PDF, 834 kB, 28.02.2024)

Applications and meetings

New application

Project Orbis

ZL000_00_048e_WL Guidance document Project Orbis (PDF, 707 kB, 24.05.2023)

COVID-19

ZL000_00_044e_WL Guidance document Authorisation procedures for Covid-19 medicinal products during a pandemic (PDF, 279 kB, 24.05.2023)

Questions and answers on the packaging and labelling requirements for medicinal products intended to prevent or combat COVID-19

SwissPAR

ZL000_00_030e_WL Guidance document SwissPAR (PDF, 303 kB, 23.05.2023)

Questions and answers Swiss Public Assessment Report (SwissPAR)

Medicinal Product Names

ZL000_00_043e_WL Guidance document Medicinal product name (PDF, 1 MB, 01.10.2023)

Mobile technologies

ZL000_00_050e_WL Guidance document Mobile technologies (PDF, 1 MB, 01.10.2023)

ZL000_00_040e_FO Mobile technologies (DOCX, 371 kB, 01.10.2023)

Authorisation of human medicinal product with new active substance

ZL101_00_005e_WL Guidance document Authorisation of human medicinal product with new active substance (PDF, 304 kB, 01.05.2023)

ZL000_00_048e_WL Guidance document Project Orbis (PDF, 707 kB, 24.05.2023)

ZL100_00_001e_FO Form New authorisation of human medicinal products (DOCX, 189 kB, 15.04.2024)

ZL000_00_032e_FO Form Full declaration (DOCX, 152 kB, 11.07.2023)

ZL000_00_037e_FO Form Manufacturer information (DOCX, 198 kB, 11.09.2023)

ZL000_00_030e_FO Form Status of authorisation applications abroad (DOCX, 155 kB, 01.04.2024)

ZL000_00_031e_FO Form Substances of animal and human origin (DOCX, 170 kB, 11.07.2023)

ZL000_00_029e_FO Form Declaration of radiopharmaceuticals (DOCX, 151 kB, 29.06.2023)

ZL000_00_028e_FO Form Confirmation regarding substances from GMO (DOCX, 152 kB, 30.06.2023)

ZL000_00_035e_FO Form DMF (DOCX, 166 kB, 29.06.2023)

ZL101_00_004e_FO Form Information for application Art.13 TPA (DOCX, 194 kB, 15.01.2024)

ZL000_00_036e_WL Guidance document GMP compliance by foreign manufacturers (PDF, 479 kB, 15.04.2024)

ZL000_00_038e_FO Form Declaration by the Responsible Person for foreign manufacturers (DOCX, 162 kB, 29.06.2023)

BW105_00_002e_VZ List Countries with recognised GMP control systems (PDF, 127 kB, 26.06.2023)

ZL000_00_035e_WL Guidance document Minimising the risk of TSE (PDF, 240 kB, 24.05.2023)

ZL109_00_001e_WL Guidance document Temporary authorisation for human medicinal products (PDF, 3 MB, 15.01.2024)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

Authorisation of human medicinal product with known active pharmaceutical substance

ZL101_00_007e_WL Guidance document Authorisation of human medicinal product with known active pharmaceutical substance (PDF, 4 MB, 15.01.2024)

ZL100_00_001e_FO Form New authorisation of human medicinal products (DOCX, 189 kB, 15.04.2024)

ZL000_00_032e_FO Form Full declaration (DOCX, 152 kB, 11.07.2023)

ZL000_00_037e_FO Form Manufacturer information (DOCX, 198 kB, 11.09.2023)

ZL000_00_030e_FO Form Status of authorisation applications abroad (DOCX, 155 kB, 01.04.2024)

ZL000_00_031e_FO Form Substances of animal and human origin (DOCX, 170 kB, 11.07.2023)

ZL000_00_029e_FO Form Declaration of radiopharmaceuticals (DOCX, 151 kB, 29.06.2023)

ZL000_00_028e_FO Form Confirmation regarding substances from GMO (DOCX, 152 kB, 30.06.2023)

ZL000_00_035e_FO Form DMF (DOCX, 166 kB, 29.06.2023)

ZL101_00_004e_FO Form Information for application Art.13 TPA (DOCX, 194 kB, 15.01.2024)

ZL000_00_036e_WL Guidance document GMP compliance by foreign manufacturers (PDF, 479 kB, 15.04.2024)

ZL000_00_038e_FO Form Declaration by the Responsible Person for foreign manufacturers (DOCX, 162 kB, 29.06.2023)

BW105_00_002e_VZ List Countries with recognised GMP control systems (PDF, 127 kB, 26.06.2023)

ZL000_00_035e_WL Guidance document Minimising the risk of TSE (PDF, 240 kB, 24.05.2023)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

Fast-track authorisation procedure

ZL104_00_002e_WL Guidance document Fast-track authorisation procedure (PDF, 2 MB, 15.01.2024)

ZL104_00_001e_FO Decision minutes Accelerated Application Hearing (DOCX, 171 kB, 29.06.2023)

Procedure with prior notification

ZL101_00_013e_WL Guidance document Procedure with prior notification (PDF, 282 kB, 01.06.2023)

ZL000_00_030e_FO Form Status of authorisation applications abroad (DOCX, 155 kB, 01.04.2024)

Paediatric investigation plan

ZL000_00_023e_WL Guidance document Paediatric investigation plan (PDF, 317 kB, 23.05.2023)

ZL000_00_034e_FO Form Paediatric investigation plan (DOCX, 332 kB, 21.09.2023)

Questions and answers on the Paediatric Investigation Plan

Document protection

ZL000_00_024e_WL Guidance document Document protection HMV4 (PDF, 565 kB, 01.01.2023)

Questions and answers on document protection

Authorisation human medicinal product under Art. 13 TPA

ZL000_00_019e_WL Guidance document Authorisation human medicinal product under Art. 13 TPA (PDF, 3 MB, 15.01.2024)

Questions and answers Art. 13 TPA

ZL101_00_004e_FO Form Information for application Art.13 TPA (DOCX, 194 kB, 15.01.2024)

ZL000_00_030e_FO Form Status of authorisation applications abroad (DOCX, 155 kB, 01.04.2024)

ZL100_00_001e_FO Form New authorisation of human medicinal products (DOCX, 189 kB, 15.04.2024)

ZL000_00_032e_FO Form Full declaration (DOCX, 152 kB, 11.07.2023)

ZL000_00_037e_FO Form Manufacturer information (DOCX, 198 kB, 11.09.2023)

ZL000_00_031e_FO Form Substances of animal and human origin (DOCX, 170 kB, 11.07.2023)

ZL000_00_029e_FO Form Declaration of radiopharmaceuticals (DOCX, 151 kB, 29.06.2023)

ZL000_00_028e_FO Form Confirmation regarding substances from GMO (DOCX, 152 kB, 30.06.2023)

ZL000_00_035e_FO Form DMF (DOCX, 166 kB, 29.06.2023)

ZL000_00_036e_WL Guidance document GMP compliance by foreign manufacturers (PDF, 479 kB, 15.04.2024)

ZL000_00_038e_FO Form Declaration by the Responsible Person for foreign manufacturers (DOCX, 162 kB, 29.06.2023)

ZL000_00_011e_VZ Directory List countries with comparable control of human medicinal products (PDF, 390 kB, 01.01.2024)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

Authorisation in accordance with Art. 14 para. 1 abis-quater TPA

ZL000_00_022e_WL Guidance document Authorisation in accordance with Art. 14 para. 1 abis-quater TPA (PDF, 2 MB, 15.01.2024)

ZL100_00_001e_FO Form New authorisation of human medicinal products (DOCX, 189 kB, 15.04.2024)

Questions and answers on Art. 14 para. 1 letter abis-quater TPA

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

Authorisation of allergen product

ZL000_00_032e_WL Guidance document Authorisation of allergen product (PDF, 300 kB, 24.05.2023)

Authorisation of antidote

ZL000_00_031e_WL Guidance document Authorisation of antidote (PDF, 253 kB, 23.05.2023)

Toxinfo Suisse

MU101_20_004d_FO UAW Antidota Antivenine (DOCX, 195 kB, 26.10.2022)

ZL000_00_036e_WL Guidance document GMP compliance by foreign manufacturers (PDF, 479 kB, 15.04.2024)

ZL000_00_038e_FO Form Declaration by the Responsible Person for foreign manufacturers (DOCX, 162 kB, 29.06.2023)

BW105_00_002e_VZ List Countries with recognised GMP control systems (PDF, 127 kB, 26.06.2023)

Authorisation of antivenin

ZL000_00_033e_WL Guidance document Authorisation of antivenin (PDF, 273 kB, 24.05.2023)

ZL000_00_033e_FO Form New authorisation variation antivenin (DOCX, 161 kB, 11.07.2023)

Toxinfo Suisse

MU101_20_004d_FO UAW Antidota Antivenine (DOCX, 195 kB, 26.10.2022)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

Authorisation biosimilar

ZL101_00_012e_WL Guidance document Authorisation biosimilar (PDF, 560 kB, 15.11.2023)

Questions and answers on the authorisation of biosimilars

ZL100_00_001e_FO Form New authorisation of human medicinal products (DOCX, 189 kB, 15.04.2024)

ZL000_00_032e_FO Form Full declaration (DOCX, 152 kB, 11.07.2023)

ZL000_00_037e_FO Form Manufacturer information (DOCX, 198 kB, 11.09.2023)

ZL000_00_030e_FO Form Status of authorisation applications abroad (DOCX, 155 kB, 01.04.2024)

ZL000_00_031e_FO Form Substances of animal and human origin (DOCX, 170 kB, 11.07.2023)

ZL000_00_029e_FO Form Declaration of radiopharmaceuticals (DOCX, 151 kB, 29.06.2023)

ZL000_00_028e_FO Form Confirmation regarding substances from GMO (DOCX, 152 kB, 30.06.2023)

ZL000_00_035e_FO Form DMF (DOCX, 166 kB, 29.06.2023)

ZL101_00_004e_FO Form Information for application Art.13 TPA (DOCX, 194 kB, 15.01.2024)

ZL000_00_036e_WL Guidance document GMP compliance by foreign manufacturers (PDF, 479 kB, 15.04.2024)

ZL000_00_038e_FO Form Declaration by the Responsible Person for foreign manufacturers (DOCX, 162 kB, 29.06.2023)

BW105_00_002e_VZ List Countries with recognised GMP control systems (PDF, 127 kB, 26.06.2023)

ZL000_00_035e_WL Guidance document Minimising the risk of TSE (PDF, 240 kB, 24.05.2023)

Authorisation of co-marketing medicinal product

ZL108_00_002e_WL Guidance document Authorisation of co-marketing medicinal product (PDF, 288 kB, 01.05.2023)

Questions and answers on co-marketing

ZL108_00_002e_FO Form New authorisation for co-marketing of medicinal product HMV4 (DOCX, 163 kB, 30.06.2023)

ZL000_00_032e_FO Form Full declaration (DOCX, 152 kB, 11.07.2023)

ZL000_00_037e_FO Form Manufacturer information (DOCX, 198 kB, 11.09.2023)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

Autorisation of parallel import

ZL106_00_888e_WL Guidance document Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import) (PDF, 517 kB, 01.01.2024)

Questions and answers Parallel imports of human medicinal products

ZL106_00_002e_FO Form Import of a human medicinal product according to Art. 14 para. 2 and 3 TPA (parallel import) (DOCX, 169 kB, 01.01.2024)

ZL000_00_036e_WL Guidance document GMP compliance by foreign manufacturers (PDF, 479 kB, 15.04.2024)

ZL000_00_038e_FO Form Declaration by the Responsible Person for foreign manufacturers (DOCX, 162 kB, 29.06.2023)

ZL000_00_011e_VZ Directory List countries with comparable control of human medicinal products (PDF, 390 kB, 01.01.2024)

Temporary authorisation for human medicinal products

ZL109_00_001e_WL Guidance document Temporary authorisation for human medicinal products (PDF, 3 MB, 15.01.2024)

Questions and answers on temporary authorisation human medicinal products

ZL104_00_001e_FO Decision minutes Accelerated Application Hearing (DOCX, 171 kB, 29.06.2023)

MU103_10_001e_WL Guidance document RMP / ICH E2E – Information for submission of RMP HMP (PDF, 2 MB, 01.11.2023)

ZL100_00_001e_FO Form New authorisation of human medicinal products (DOCX, 189 kB, 15.04.2024)

ZL000_00_032e_FO Form Full declaration (DOCX, 152 kB, 11.07.2023)

ZL000_00_037e_FO Form Manufacturer information (DOCX, 198 kB, 11.09.2023)

ZL101_00_004e_FO Form Information for application Art.13 TPA (DOCX, 194 kB, 15.01.2024)

ZL000_00_030e_FO Form Status of authorisation applications abroad (DOCX, 155 kB, 01.04.2024)

ZL000_00_036e_WL Guidance document GMP compliance by foreign manufacturers (PDF, 479 kB, 15.04.2024)

ZL000_00_038e_FO Form Declaration by the Responsible Person for foreign manufacturers (DOCX, 162 kB, 29.06.2023)

BW105_00_002e_VZ List Countries with recognised GMP control systems (PDF, 127 kB, 26.06.2023)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

Authorisation of medicinal gas

ZL000_00_016e_WL Guidance document Authorisation of medicinal gas (PDF, 276 kB, 22.05.2023)

Authorisation radiopharmaceutical

ZL000_00_034e_WL Guidance document Authorisation radiopharmaceutical (PDF, 463 kB, 24.05.2023)

ZL000_00_042e_WL Guidance document Maintenance and updating of Annex 1 (PDF, 251 kB, 24.05.2023)

ZL000_00_029e_FO Form Declaration of radiopharmaceuticals (DOCX, 151 kB, 29.06.2023)

BW107_00_002d_PB Befristete Vertriebsbewilligung Radiopharmazeutika (PDF, 203 kB, 01.02.2016)

BW107_00_003d_FO Gesuch befristete Vertriebsbewilligung Radiopharmazeutika (DOCX, 170 kB, 04.04.2016)

Authorisation of individual teas, cough and throat lozenges and pastilles in the notification procedure

ZL103_00_003e_WL Guidance document Authorisation of individual teas, cough and throat lozenges and pastilles in the notification procedure HMV4 (PDF, 306 kB, 29.01.2019)

ZL100_00_001e_FO Form New authorisation of human medicinal products (DOCX, 189 kB, 15.04.2024)

ZL103_00_003e_FO Form New authorisation variation in notification procedure KPTPO (DOCX, 178 kB, 29.06.2023)

ZL000_00_032e_FO Form Full declaration (DOCX, 152 kB, 11.07.2023)

ZL000_00_030e_FO Form Status of authorisation applications abroad (DOCX, 155 kB, 01.04.2024)

ZL000_00_031e_FO Form Substances of animal and human origin (DOCX, 170 kB, 11.07.2023)

ZL000_00_035e_WL Guidance document Minimising the risk of TSE (PDF, 240 kB, 24.05.2023)

Renewal of autorisation

ZL000_00_032e_FO Form Full declaration (DOCX, 152 kB, 11.07.2023)

ZL000_00_037e_FO Form Manufacturer information (DOCX, 198 kB, 11.09.2023)

ZL000_00_029e_FO Form Declaration of radiopharmaceuticals (DOCX, 151 kB, 29.06.2023)

ZL000_00_028e_FO Form Confirmation regarding substances from GMO (DOCX, 152 kB, 30.06.2023)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

QR restrictions after first authorisation

ZL300_00_003e_FO Form Variations and extensions HAM (DOCX, 705 kB, 15.10.2023)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

Authorisation under the MAGHP procedure

ZL000_00_047e_WL Guidance document MAGHP Procedure (PDF, 446 kB, 25.05.2023)

Variations and extensions

ZL300_00_001e_WL Guidance document Variations and extensions HAM (PDF, 2 MB, 01.02.2024)

ZL000_00_048e_WL Guidance document Project Orbis (PDF, 707 kB, 24.05.2023)

ZL300_00_003e_FO Form Variations and extensions HAM (DOCX, 705 kB, 15.10.2023)

Questions and answers on variations and extensions HMP

ZL000_00_035e_WL Guidance document Minimising the risk of TSE (PDF, 240 kB, 24.05.2023)

ZL000_00_032e_FO Form Full declaration (DOCX, 152 kB, 11.07.2023)

ZL000_00_037e_FO Form Manufacturer information (DOCX, 198 kB, 11.09.2023)

ZL000_00_030e_FO Form Status of authorisation applications abroad (DOCX, 155 kB, 01.04.2024)

ZL000_00_031e_FO Form Substances of animal and human origin (DOCX, 170 kB, 11.07.2023)

ZL000_00_029e_FO Form Declaration of radiopharmaceuticals (DOCX, 151 kB, 29.06.2023)

ZL000_00_028e_FO Form Confirmation regarding substances from GMO (DOCX, 152 kB, 30.06.2023)

ZL000_00_035e_FO Form DMF (DOCX, 166 kB, 29.06.2023)

ZL000_00_019e_WL Guidance document Authorisation human medicinal product under Art. 13 TPA (PDF, 3 MB, 15.01.2024)

ZL101_00_004e_FO Form Information for application Art.13 TPA (DOCX, 194 kB, 15.01.2024)

ZL000_00_036e_WL Guidance document GMP compliance by foreign manufacturers (PDF, 479 kB, 15.04.2024)

ZL000_00_038e_FO Form Declaration by the Responsible Person for foreign manufacturers (DOCX, 162 kB, 29.06.2023)

BW105_00_002e_VZ List Countries with recognised GMP control systems (PDF, 127 kB, 26.06.2023)

ZL000_00_050e_WL Guidance document Mobile technologies (PDF, 1 MB, 01.10.2023)

ZL000_00_040e_FO Mobile technologies (DOCX, 371 kB, 01.10.2023)

Approval variation of authorisation holder

ZL404_00_001e_WL Guidance documentTransfer of marketing authorisation (PDF, 238 kB, 01.05.2023)

Questions and answers on the transfer of authorisation and orphan drug status

ZL100_00_001e_FO Form New authorisation of human medicinal products (DOCX, 189 kB, 15.04.2024)

ZL404_00_001e_FO Form Transfer of authorisation (DOCX, 162 kB, 17.07.2023)

BW303_00_003e_WL Guidance document Change name or domicile of the authorisation holder (PDF, 476 kB, 23.02.2023)

Renewal and discontinuation of authorisation or change of status (main authorisation/export licence)

ZL201_00_001e_WL Guidance document Renewal and discontinuation of authorisation or change of status (main authorisation/export licence) (PDF, 327 kB, 01.05.2023)

Questions and answers on authorisation renewals

ZL201_00_008e_FO Form Renewal of authorisation (DOCX, 160 kB, 19.07.2023)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

No marketing / interruption of distribution

ZL203_00_002e_WL Guidance document No marketing / interruption of distribution (PDF, 244 kB, 01.05.2023)

ZL203_00_002e_FO Form No marketing / interruption of distribution (DOCX, 159 kB, 28.06.2023)

OS000_00_001e_FO Technical Validation eCTD - Part1 (Swiss eCTD Validation Criteria v 1.2) (DOCX, 361 kB, 19.07.2023)

Supplementary information

Archiving of specification documents

Top of page

Human medicinal product

Schweizerisches Heilmittelinstitut
Institut suisse des produits thérapeutiques
Istituto svizzero per gli agenti terapeutici
Swiss Agency for Therapeutic Products

Swissmedic

Human medicinal product

Orphan drug application TPO4

Fast-track application TPO4

Procedure with prior notification TPO4

Temporary authorisation TPO4

Company meetings relating to authorisation TPO4

Main Navigation

Swissmedic

Search

Breadcrumb

Human medicinal product

Orphan drug application TPO4

Fast-track application TPO4

Procedure with prior notification TPO4

Temporary authorisation TPO4

Company meetings relating to authorisation TPO4

Supplementary information